ログイン

immuno 3
100問 • 7ヶ月前
  • ユーザ名非公開
  • 通報

    問題一覧

  • 1

    IgG that does not fix complement

    igG4

  • 2

    Major immunoglobulin in anamnestic response

    igG

  • 3

    Predominant Ig in secretions

    IgA

  • 4

    Second to be present in B-cell suface; mature bcell Serves as a function in immunoregulation;

    ig A

  • 5

    Mediates some type of hypersensitivity reactions, allergies and anaphylaxis; responsible for immunity in invading parasites; Binds strongly to a receptor on mast cells and basophils; mediates release of histamine

    igE

  • 6

    Another name for igE

    reagin

  • 7

    tHis complement functions in opsonization

    C 3b

  • 8

    Complemment acting in cell lysis

    C3b6789

  • 9

    A regulatroy protein that cleaves C3b and C4b

    factor I

  • 10

    Cofactor with Factor i to inactivate C 3B; prevents binding of B to C3b

    factor h

  • 11

    Acts as a cofactor with factor I to inactivate C4b

    C4

  • 12

    Prevents attachment to C5b67 complex to cell membranes

    s protein

  • 13

    Block assembly of MAC; membrane inhibitor of reactive lysis

    CD59

  • 14

    Binds to C8 therefore prevents formation of MAC

    homologous restriction factor

  • 15

    Prevents assembly of C3 convertase

    decay accelerating factor

  • 16

    Trimolecular structure stabilized by calcium

    C 1

  • 17

    6 globular structure, 2 of which must attach to Fc

    c1 q

  • 18

    Activation unit in classical pathway

    c4, c3, c2

  • 19

    Membrane attack complex is composed of: C56789 ; what is the start?

    c5b

  • 20

    This pathway is initiated by iga aggregates; yeast cells; and a cobra venom factor

    alternate pathway

  • 21

    This pathway is initiated by microorganisms with mannose

    lectin pathway

  • 22

    what are the anaphylatoxins in the complements

    c3a, c4a, c5a

  • 23

    What are the opsonins in the complement

    c3b, c4b, c5b

  • 24

    This complement increases permeability

    c2b

  • 25

    This ion stabilizes C1 complex

    ca

  • 26

    This complement is involved in chemotaxin

    c5a

  • 27

    Deficiency in this complement: Hereditary angioneurotic edema( hane)

    c1 inh

  • 28

    Deficiency in this complement: Glomerulonephritis

    c3

  • 29

    Deficiency in this complement: Recurrent infections in neisseria spp

    c5, 6, 7, 8

  • 30

    No known disease asociation

    c9

  • 31

    Complements involved in PNH except

    c1 inh

  • 32

    Complements involved in Lupus like syndrome

    c3

  • 33

    The most common deficiency

    c2

  • 34

    Most severe deficiency

    c3

  • 35

    A method used for screen for individual complement components

    radial immunodiffusion

  • 36

    This measures concentation according to the amount of light scattered by a solution containin an antibody and a measured patient sample

    nephelometry

  • 37

    Most commonly used functional assay; this measures the amount if px serum required to lyse 50% of a standardized cooncentration of antibody-sensitized sheep erythrocytes

    hemolytic titration

  • 38

    An additional CH50 test that has been developed based on the lysis of liposomes; most accurate tha traditional CH50

    liposome lysis

  • 39

    Rabbit red blood cell that have been sensitized with antibody are implanted in agarose, and patient serum is added to wells punched in the gel

    radial hemolysis

  • 40

    Solid-phase igM attached to the walls of microtiter plates is used to initiate complement activation. Antihuman antibody to c9 conjugated to alkaline phosphatase is the indicator of complement activation

    ELISA

  • 41

    Th beset screen for complement abnormalities

    ELISA

  • 42

    An alternate pathway assa that is performed in the same manner as CH50 , except magnesium chloride and edta, and calcium is left out; indicator: RABBIT RED CELLS

    ah50

  • 43

    Tests that uses complement as the reagent; can detect the presence of antigen or antibody in the sample; used for the detection f viral, fungal and rickettsial antibodies

    complement fixation tessts

  • 44

    Tumor marker involved in medullary thyroid cancer

    calcitonin

  • 45

    Head and neck tumors, lung cancer, for the detection of stage IV breast cancer, recurrence and metastasis

    CYFRA 21-2

  • 46

    Nonseminomatous testicular cancer, CHORIOCARCINOMA

    HCG

  • 47

    tHe antibodies involved are anti-glutamic acid decarboxylase , anti-insulin , anti-insulinoma antigen 2 abs, IL- 2 ba(phogrin) ICA ( islet cells abs) HLA -DR3 and HLA- DR4

    type I DM

  • 48

    HLA involved is HLA-DR4

    rheumatoid arthritis

  • 49

    Antibodies involved are: Anti-tsh receptor antibodies, elevated T 3 and T4 are first tested, low TSH levels, increased radioactive iodine uptake

    grave's disease

  • 50

    Antibodies involved: Anti-thyroidd peroxidase Anti-thyroglobulin antibodies

    hashimoto's disease

  • 51

    Antibodies involved are anti-parietal cells, anti-intrinsic factor antibodies

    pernicious anemia

  • 52

    HLA involved in graves disease

    hla-dr3

  • 53

    A neuromuscular transmission disorder due to antibodies that inhibit and block acetylcholine binding

    myasthenia gravis

  • 54

    Skin fibroblasts reproduce faster and secrete more collagen

    scleroderma

  • 55

    Clinically presents as dry eys and mouth; hla-dr3

    sjogren's syndrome

  • 56

    Antibody involved in antiglomerular basement membrane antibodies

    goodpasture's syndrome

  • 57

    Antineutrophilic cytoplasmic antibodies

    wegener's granulomatosus

  • 58

    Antimitochondrial antibodies

    primary billiary cirrhosis

  • 59

    Antismooth muscle antibodies

    chronic active hepatitis

  • 60

    Hla involved in chronic active hepatitis

    HLA B8

  • 61

    A benign or malignant condition that results from a single clone of lymphoid-plasma cels producig elevated levels of a single class of and type of immunglobulin

    monoclonal gammopathy

  • 62

    Malignancy of mature plasma cells; excess plasma cells in the bone marrow, and lytic bone lesions

    multiple myeloma

  • 63

    Malignant proliferation of igM-producing lymphocytes and corresponds to lymphoplasmacytoid lymphoma

    waldenstrom macroglobulinemia

  • 64

    X-linked recessive disorder; defect in NADPH oxidase system; reduced intracellular killing of ingested organisms; NBT is used for diagnosis

    Chronic granulomatous disease

  • 65

    Deficiency of an enzyme that is important in microbicidal agent in neutrophils

    myeloperoxidase deficiency

  • 66

    Impaired chemotaxis and phagosom degranulation; presence if giant granules in WBCs

    chediak-higashi syndrome

  • 67

    Neutrophils demonstrate defective chemotaxis

    job's syndrome

  • 68

    Defective chemotactic and random movement by neutrophils

    lazy leukocyte syndrome

  • 69

    Deficiency of a phagocytosis-promoting serum tetrapeptide that is cleave from an ig like molecule, leukokinin n the spleen

    tuftsin deficiency

  • 70

    Lack of CD18

    leukocyte adhesion deficiency

  • 71

    Genetic defect in th long arm of x chromosome; block in the maturation of pre b cells; recurrent infections involved: strep, staph, pseudomonas, and hemophilus

    bruton's x-linked aggamaglobulinemia

  • 72

    Arrest in the develoment of b-cells is the culprit

    selective Ig deficiency(dysgammaglobulinemia)

  • 73

    Recurrent sinopulmonary infections; iga levels lower than5 mg/dl

    selective Ig A deficiencye

  • 74

    Results when the onset of Ig synthesis is delayed; common in infants between5th and 6ht months of life

    transient hypogammaglobulinemia

  • 75

    Mostcommon form of selective ig deficiency

    selective Ig A deficiency

  • 76

    Faulty development of3rd nd th pharyngeal pouches; associated with defect of chromosome22

    digeorges syndrome

  • 77

    Conegnital thymic hypoplasia

    digeorge syndrome

  • 78

    Impaired synthesis of MIf by T-cells; migratory inhibitory factor

    chronic cutaneous candidiasis

  • 79

    Dificeincy in th e epxression of MHC II gene products in the tcells surface leading to failure of antigen presentation

    bare lymphocyte syndrome

  • 80

    A combined b cell and t cell disorded that has a combined defetct of both humoral and cell mediated immunity; autosomal recessive type is associated deaminase deficiency; rarely survive beyond age1

    severe combined immunodeficiency disease

  • 81

    Thymic dysplasia resulting in decreased to absent t-cell immunity; usually have marked lymphadenopathy and hepatosplenomegaly

    nezelof's syndrome

  • 82

    Mutation in the WASP gene

    wiskott aldrich syndrome

  • 83

    Result of specific genetic defect that affects DNA repair

    ataxia telangiectasia

  • 84

    Mutation in SH2 DAI/ SAP gene resulting in weakening both cellular and humoral immunity; vulnerability to EBV infection

    x liked lymphoproliferative diseases

  • 85

    A type of hypersensitivity: Anaphylactic; no complement; igE mediated; hay fever, asthma, food allergies

    type1

  • 86

    A type of hypersensitivity: Cytotoxic; Complement involved; IgG or IgM mediated; transfusion reactions, HDN, autoimmune Hemolytic anemia

    type 2

  • 87

    A type of hypersensitivity; immune complex; complement involved; neutrophils and monocytes; IMMUN COMPLEX DEPOSIITON; SLE

    type 3

  • 88

    A type of hypersensitivity: T cell dependent; no complement and no antibody involved; release of CYTOKINES

    type 4

  • 89

    PSOT STRP GN; ARTHUS REAX; FARMER'S LUNGS SERUM SICKNESS are examples of what type of hypersensitivity

    type 3

  • 90

    DAT test and IAT test are test for what type of hypersensitivity

    type 2

  • 91

    Contact dermatitis; mantoux reax; hypersensitivity pneumolith are what type of hypersensitivity

    type 4

  • 92

    Gold standard for contact dermatitis(type4)

    patch test

  • 93

    Most severe formof allergic response; low BP; low blood volume; caused by stings or food allergies

    anaphylaxis

  • 94

    Measures total IgE

    Radio immunosorbent assay

  • 95

    Masures antigen-specific IgE

    RAST

  • 96

    Triggered by antigens found on cell surfaces

    type2 hypersensitivity

  • 97

    Used to identify th presence of igG, C3B and C3d

    monospecific AHG

  • 98

    A mixtures of antibodies to detect igG , C3b and C3d

    polyspecific ahg

  • 99

    Th 1 plays the major role in this type of hypersensitivity

    type4 hypersensitivity

  • 100

    Positive result: induration measuring>/= 5mm

    mantoux reax

  • hema2 pt 2

    hema2 pt 2

    ユーザ名非公開 · 19問 · 7ヶ月前

    hema2 pt 2

    hema2 pt 2

    19問 • 7ヶ月前
    ユーザ名非公開

    immuno 1

    immuno 1

    ユーザ名非公開 · 100問 · 7ヶ月前

    immuno 1

    immuno 1

    100問 • 7ヶ月前
    ユーザ名非公開

    immuno 2

    immuno 2

    ユーザ名非公開 · 100問 · 7ヶ月前

    immuno 2

    immuno 2

    100問 • 7ヶ月前
    ユーザ名非公開

    sero1

    sero1

    ユーザ名非公開 · 100問 · 7ヶ月前

    sero1

    sero1

    100問 • 7ヶ月前
    ユーザ名非公開

    sero2

    sero2

    ユーザ名非公開 · 44問 · 7ヶ月前

    sero2

    sero2

    44問 • 7ヶ月前
    ユーザ名非公開

    問題一覧

  • 1

    IgG that does not fix complement

    igG4

  • 2

    Major immunoglobulin in anamnestic response

    igG

  • 3

    Predominant Ig in secretions

    IgA

  • 4

    Second to be present in B-cell suface; mature bcell Serves as a function in immunoregulation;

    ig A

  • 5

    Mediates some type of hypersensitivity reactions, allergies and anaphylaxis; responsible for immunity in invading parasites; Binds strongly to a receptor on mast cells and basophils; mediates release of histamine

    igE

  • 6

    Another name for igE

    reagin

  • 7

    tHis complement functions in opsonization

    C 3b

  • 8

    Complemment acting in cell lysis

    C3b6789

  • 9

    A regulatroy protein that cleaves C3b and C4b

    factor I

  • 10

    Cofactor with Factor i to inactivate C 3B; prevents binding of B to C3b

    factor h

  • 11

    Acts as a cofactor with factor I to inactivate C4b

    C4

  • 12

    Prevents attachment to C5b67 complex to cell membranes

    s protein

  • 13

    Block assembly of MAC; membrane inhibitor of reactive lysis

    CD59

  • 14

    Binds to C8 therefore prevents formation of MAC

    homologous restriction factor

  • 15

    Prevents assembly of C3 convertase

    decay accelerating factor

  • 16

    Trimolecular structure stabilized by calcium

    C 1

  • 17

    6 globular structure, 2 of which must attach to Fc

    c1 q

  • 18

    Activation unit in classical pathway

    c4, c3, c2

  • 19

    Membrane attack complex is composed of: C56789 ; what is the start?

    c5b

  • 20

    This pathway is initiated by iga aggregates; yeast cells; and a cobra venom factor

    alternate pathway

  • 21

    This pathway is initiated by microorganisms with mannose

    lectin pathway

  • 22

    what are the anaphylatoxins in the complements

    c3a, c4a, c5a

  • 23

    What are the opsonins in the complement

    c3b, c4b, c5b

  • 24

    This complement increases permeability

    c2b

  • 25

    This ion stabilizes C1 complex

    ca

  • 26

    This complement is involved in chemotaxin

    c5a

  • 27

    Deficiency in this complement: Hereditary angioneurotic edema( hane)

    c1 inh

  • 28

    Deficiency in this complement: Glomerulonephritis

    c3

  • 29

    Deficiency in this complement: Recurrent infections in neisseria spp

    c5, 6, 7, 8

  • 30

    No known disease asociation

    c9

  • 31

    Complements involved in PNH except

    c1 inh

  • 32

    Complements involved in Lupus like syndrome

    c3

  • 33

    The most common deficiency

    c2

  • 34

    Most severe deficiency

    c3

  • 35

    A method used for screen for individual complement components

    radial immunodiffusion

  • 36

    This measures concentation according to the amount of light scattered by a solution containin an antibody and a measured patient sample

    nephelometry

  • 37

    Most commonly used functional assay; this measures the amount if px serum required to lyse 50% of a standardized cooncentration of antibody-sensitized sheep erythrocytes

    hemolytic titration

  • 38

    An additional CH50 test that has been developed based on the lysis of liposomes; most accurate tha traditional CH50

    liposome lysis

  • 39

    Rabbit red blood cell that have been sensitized with antibody are implanted in agarose, and patient serum is added to wells punched in the gel

    radial hemolysis

  • 40

    Solid-phase igM attached to the walls of microtiter plates is used to initiate complement activation. Antihuman antibody to c9 conjugated to alkaline phosphatase is the indicator of complement activation

    ELISA

  • 41

    Th beset screen for complement abnormalities

    ELISA

  • 42

    An alternate pathway assa that is performed in the same manner as CH50 , except magnesium chloride and edta, and calcium is left out; indicator: RABBIT RED CELLS

    ah50

  • 43

    Tests that uses complement as the reagent; can detect the presence of antigen or antibody in the sample; used for the detection f viral, fungal and rickettsial antibodies

    complement fixation tessts

  • 44

    Tumor marker involved in medullary thyroid cancer

    calcitonin

  • 45

    Head and neck tumors, lung cancer, for the detection of stage IV breast cancer, recurrence and metastasis

    CYFRA 21-2

  • 46

    Nonseminomatous testicular cancer, CHORIOCARCINOMA

    HCG

  • 47

    tHe antibodies involved are anti-glutamic acid decarboxylase , anti-insulin , anti-insulinoma antigen 2 abs, IL- 2 ba(phogrin) ICA ( islet cells abs) HLA -DR3 and HLA- DR4

    type I DM

  • 48

    HLA involved is HLA-DR4

    rheumatoid arthritis

  • 49

    Antibodies involved are: Anti-tsh receptor antibodies, elevated T 3 and T4 are first tested, low TSH levels, increased radioactive iodine uptake

    grave's disease

  • 50

    Antibodies involved: Anti-thyroidd peroxidase Anti-thyroglobulin antibodies

    hashimoto's disease

  • 51

    Antibodies involved are anti-parietal cells, anti-intrinsic factor antibodies

    pernicious anemia

  • 52

    HLA involved in graves disease

    hla-dr3

  • 53

    A neuromuscular transmission disorder due to antibodies that inhibit and block acetylcholine binding

    myasthenia gravis

  • 54

    Skin fibroblasts reproduce faster and secrete more collagen

    scleroderma

  • 55

    Clinically presents as dry eys and mouth; hla-dr3

    sjogren's syndrome

  • 56

    Antibody involved in antiglomerular basement membrane antibodies

    goodpasture's syndrome

  • 57

    Antineutrophilic cytoplasmic antibodies

    wegener's granulomatosus

  • 58

    Antimitochondrial antibodies

    primary billiary cirrhosis

  • 59

    Antismooth muscle antibodies

    chronic active hepatitis

  • 60

    Hla involved in chronic active hepatitis

    HLA B8

  • 61

    A benign or malignant condition that results from a single clone of lymphoid-plasma cels producig elevated levels of a single class of and type of immunglobulin

    monoclonal gammopathy

  • 62

    Malignancy of mature plasma cells; excess plasma cells in the bone marrow, and lytic bone lesions

    multiple myeloma

  • 63

    Malignant proliferation of igM-producing lymphocytes and corresponds to lymphoplasmacytoid lymphoma

    waldenstrom macroglobulinemia

  • 64

    X-linked recessive disorder; defect in NADPH oxidase system; reduced intracellular killing of ingested organisms; NBT is used for diagnosis

    Chronic granulomatous disease

  • 65

    Deficiency of an enzyme that is important in microbicidal agent in neutrophils

    myeloperoxidase deficiency

  • 66

    Impaired chemotaxis and phagosom degranulation; presence if giant granules in WBCs

    chediak-higashi syndrome

  • 67

    Neutrophils demonstrate defective chemotaxis

    job's syndrome

  • 68

    Defective chemotactic and random movement by neutrophils

    lazy leukocyte syndrome

  • 69

    Deficiency of a phagocytosis-promoting serum tetrapeptide that is cleave from an ig like molecule, leukokinin n the spleen

    tuftsin deficiency

  • 70

    Lack of CD18

    leukocyte adhesion deficiency

  • 71

    Genetic defect in th long arm of x chromosome; block in the maturation of pre b cells; recurrent infections involved: strep, staph, pseudomonas, and hemophilus

    bruton's x-linked aggamaglobulinemia

  • 72

    Arrest in the develoment of b-cells is the culprit

    selective Ig deficiency(dysgammaglobulinemia)

  • 73

    Recurrent sinopulmonary infections; iga levels lower than5 mg/dl

    selective Ig A deficiencye

  • 74

    Results when the onset of Ig synthesis is delayed; common in infants between5th and 6ht months of life

    transient hypogammaglobulinemia

  • 75

    Mostcommon form of selective ig deficiency

    selective Ig A deficiency

  • 76

    Faulty development of3rd nd th pharyngeal pouches; associated with defect of chromosome22

    digeorges syndrome

  • 77

    Conegnital thymic hypoplasia

    digeorge syndrome

  • 78

    Impaired synthesis of MIf by T-cells; migratory inhibitory factor

    chronic cutaneous candidiasis

  • 79

    Dificeincy in th e epxression of MHC II gene products in the tcells surface leading to failure of antigen presentation

    bare lymphocyte syndrome

  • 80

    A combined b cell and t cell disorded that has a combined defetct of both humoral and cell mediated immunity; autosomal recessive type is associated deaminase deficiency; rarely survive beyond age1

    severe combined immunodeficiency disease

  • 81

    Thymic dysplasia resulting in decreased to absent t-cell immunity; usually have marked lymphadenopathy and hepatosplenomegaly

    nezelof's syndrome

  • 82

    Mutation in the WASP gene

    wiskott aldrich syndrome

  • 83

    Result of specific genetic defect that affects DNA repair

    ataxia telangiectasia

  • 84

    Mutation in SH2 DAI/ SAP gene resulting in weakening both cellular and humoral immunity; vulnerability to EBV infection

    x liked lymphoproliferative diseases

  • 85

    A type of hypersensitivity: Anaphylactic; no complement; igE mediated; hay fever, asthma, food allergies

    type1

  • 86

    A type of hypersensitivity: Cytotoxic; Complement involved; IgG or IgM mediated; transfusion reactions, HDN, autoimmune Hemolytic anemia

    type 2

  • 87

    A type of hypersensitivity; immune complex; complement involved; neutrophils and monocytes; IMMUN COMPLEX DEPOSIITON; SLE

    type 3

  • 88

    A type of hypersensitivity: T cell dependent; no complement and no antibody involved; release of CYTOKINES

    type 4

  • 89

    PSOT STRP GN; ARTHUS REAX; FARMER'S LUNGS SERUM SICKNESS are examples of what type of hypersensitivity

    type 3

  • 90

    DAT test and IAT test are test for what type of hypersensitivity

    type 2

  • 91

    Contact dermatitis; mantoux reax; hypersensitivity pneumolith are what type of hypersensitivity

    type 4

  • 92

    Gold standard for contact dermatitis(type4)

    patch test

  • 93

    Most severe formof allergic response; low BP; low blood volume; caused by stings or food allergies

    anaphylaxis

  • 94

    Measures total IgE

    Radio immunosorbent assay

  • 95

    Masures antigen-specific IgE

    RAST

  • 96

    Triggered by antigens found on cell surfaces

    type2 hypersensitivity

  • 97

    Used to identify th presence of igG, C3B and C3d

    monospecific AHG

  • 98

    A mixtures of antibodies to detect igG , C3b and C3d

    polyspecific ahg

  • 99

    Th 1 plays the major role in this type of hypersensitivity

    type4 hypersensitivity

  • 100

    Positive result: induration measuring>/= 5mm

    mantoux reax